Methylglyoxal (MGO) inhibits proliferation and induces cell death of human glioblastoma multiforme T98G and U87MG cells

Biomedicine and Pharmacotherapy

Volumn 80, Issue , 2016, Pages 236-243

  Paul Samojedny, Monika ^a   Łasut, Barbara ^a   Pudełko, Adam ^a   Fila Daniłow, Anna ^a   Kowalczyk, Małgorzata ^a   Suchanek Raif, Renata ^a   Zieliński, Michał ^a   Borkowska, Paulina ^a   Kowalski, Jan ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Apoptosis; Cell cycle; Glioblastoma multiforme; Methylglyoxal; Proliferation; Significance statement

Indexed keywords

METHYLGLYOXAL;

AIR; APOPTOSIS; ARTICLE; ATMOSPHERE; BIOACCUMULATION; CANCER PROGNOSIS; CELL AGING; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SERUM; T98G CELL LINE; U87.CD4 CELL LINE; CELL CYCLE; DRUG EFFECTS; NECROSIS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; GLIOBLASTOMA; HUMANS; NECROSIS; PYRUVALDEHYDE;

EID: 85021851917     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.03.021     Document Type: Article

References (29)

1. Amicarelli, F., Bucciarelli, T., Poma, A., Aimola, P., Di Ilio, C., Ragnelli, A.M., Miranda, M., Adaptive response of human melanoma cells to methylglyoxal injury. Carcinogenesis 19 (1998), 519–523.
2. Amicarelli, F., Colafarina, S., Cattani, F., Cimini, A., Di Ilio, C., Ceru, M.P., Miranda, M., Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radic. Biol. Med. 35 (2003), 856–871.
3. Ayoub, F.M., Allen, R.E., Thornalley, P.J., Inhibition of proliferation of human leukaemia 60 cells by methylglyoxal in vitro. Leuk. Res. 17 (1993), 397–401.
4. Bhattacharyya, N., Pal, A., Patra, S., Haldar, A.K., Roy, S., Ray, M., Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host. Int. Immunopharmacol. 8 (2008), 1503–1512.
5. Biswas, S., Ray, M., Misra, S., Dutta, D.P., Ray, S., Selective inhibition of mitochondrial respiration and glycolysis in human leukaemic leucocytes by methylglyoxal. Biochem. J. 323:Pt. 2 (1997), 343–348.
6. Cantero, A.-V., Portero-Otín, M., Ayala, V., Auge, N., Sanson, M., Elbaz, M., Thiers, J.-C., Pamplona, R., Salvayre, R., Nègre-Salvayre, A., Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. FASEB J. 21 (2007), 3096–3106.
7. Chang, Y.-C., Hsieh, M.-C., Wu, H.-J., Wu, W.-C., Kao, Y.-H., Methylglyoxal, a reactive glucose metabolite, enhances autophagy flux and suppresses proliferation of human retinal pigment epithelial ARPE-19 cells. Toxicol. In Vitro 29 (2015), 1358–1368.
8. Chan, W.-H., Wu, H.-J., Shiao, N.-H., Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J. Cell. Biochem. 100 (2007), 1056–1069.
9. Darzynkiewicz, Z., Robinson, J.P., Crissman, H.A., (eds.) Flow Cytometry. Methods in Cell Biology, vol. 41 & 42, 1994, Academic Press, Inc., San Diego.
10. Davis, F.G., McCarthy, B.J., Current epidemiological trends and surveillance issues in brain tumors. Expert Rev. Anticancer Ther. 1 (2001), 395–401.
11. Du, J., Suzuki, H., Nagase, F., Akhand, A.A., Ma, X.Y., Yokoyama, T., Miyata, T., Nakashima, I., Superoxide-mediated early oxidation and activation of ASK1 are important for initiating methylglyoxal-induced apoptosis process. Free Radic. Biol. Med. 31 (2001), 469–478.
12. Gutenberg, A., Lumenta, C.B., Braunsdorf, W.E.K., Sabel, M., Mehdorn, H.M., Westphal, M., Giese, A., The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience. J. Neurooncol. 113 (2013), 163–174.
13. Halder, J., Ray, M., Ray, S., Inhibition of glycolysis and mitochondrial respiration of Ehrlich ascites carcinoma cells by methylglyoxal. Int. J. Cancer 54 (1993), 443–449.
14. Hansen, F., de Souza, D.F., Silveira, Sda L., Hoefel, A.L., Fontoura, J.B., Tramontina, A.C., Bobermin, L.D., Leite, M.C., Perry, M.L., Gonçalves, C.A., Methylglyoxal alters glucose metabolism and increases AGEs content in C6 glioma cells. Metab. Brain Dis. 27:4 (2012), 531–539.
15. Henery, S., George, T., Hall, B., Basiji, D., Ortyn, W., Morrissey, P., Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: a comparison with standard photometric methods. Apoptosis 13 (2008), 1054–1063.
16. Huse, J.T., Holland, E.C., Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat. Rev. Cancer 10 (2010), 319–331.
17. Kang, Y., Edwards, L.G., Thornalley, P.J., Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA G1 growth arrest and induction of apoptosis. Leuk. Res. 20 (1996), 397–405.
18. Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W., Kleihues, P., The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114 (2007), 97–109.
19. Maessen, D.E.M., Stehouwer, C.D.A., Schalkwijk, C.G., The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin. Sci. 128 (2015), 839–861.
20. Milanesa, D.M., Choudhury, M.S., Mallouh, C., Tazaki, H., Konno, S., Methylglyoxal-induced apoptosis in human prostate carcinoma: potential modality for prostate cancer treatment. Eur. Urol. 37 (2000), 728–734.
21. Menzel, M., Asperger, A., Renner, C., Meixensberger, J., Gaunitz, F., Methylglyoxal and carnosine synergistically deplete ATP in glioblastoma cells. 62nd Annual Meeting of the German Society of Neurosurgery (DGNC) Joint Meeting with the Polish Society of Neurosurgeons (PNCH) German Society of Neurosurgery (DGNC), 7–11 May 2011, Hamburg, 2016.
22. Okado, A., Kawasaki, Y., Hasuike, Y., Takahashi, M., Teshima, T., Fujii, J., Taniguchi, N., Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem. Biophys. Res. Commun. 225 (1996), 219–224.
23. Pal, A., Bhattacharya, I., Bhattacharya, K., Mandal, C., Ray, M., Methylglyoxal induced activation of murine peritoneal macrophages and surface markers of T lymphocytes in sarcoma-180 bearing mice: involvement of MAP kinase, NF-kappa beta signal transduction pathway. Mol. Immunol. 46 (2009), 2039–2044.
24. Paul-Samojedny, M., Suchanek, R., Borkowska, P., Pudełko, A., Owczarek, A., Kowalczyk, M., Machnik, G., Fila-Daniłow, A., Kowalski, J., Knockdown of AKT3 (PKBł) and PI3KCA suppresses cell viability and proliferation and induces the apoptosis of glioblastoma multiforme T98G cells. Biomed. Res. Int., 2014, 2014, 768181.
25. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J.B., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352 (2005), 987–996.
26. Talukdar, D., Ray, S., Das, S., Jain, A.K., Kulkarni, A., Ray, M., Treatment of a number of cancer patients suffering from different types of malignancies by methylglyoxal-based formulation: a promising result. Cancer Ther. 4B (2006), 205–222.
27. Talukdar, D., Ray, S., Ray, M., Das, S., A Brief critical overview of the biological effects of methylglyoxal and further evaluation of a methylglyoxal-based anticancer formulation in treating cancer patients. Drug Metabol. Drug Interact. 23 (2008), 175–210.
28. Taniguchi, H., Horinaka, M., Yoshida, T., Yano, K., Goda, A.E., Yasuda, S., Wakada, M., Sakai, T., Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregulating the expression of antiapoptotic molecules. Mol. Cancer Ther. 11 (2012), 2294–2300.
29. Van Herreweghe, F., Mao, J., Chaplen, F.W.R., Grooten, J., Gevaert, K., Vandekerckhove, J., Vancompernolle, K., Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 949–954.